RI
PMVP icon

RTW Investments’s PMV Pharmaceuticals PMVP Stock Holding History

RTW Investments’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,375,785
Closed -$14.6M – 71
2023
Q3 		$14.6M Sell
2,375,785
-653,766
-22% -$4.5M 0.31% 43
2023
Q2 		$19M Buy
3,029,551
+30,453
+1% +$160K 0.36% 40
2023
Q1 		$14.3M Sell
2,999,098
-1,357,822
-31% -$9.56M 0.3% 39
2022
Q4 		$37.9M Hold
4,356,920
– – 0.77% 29
2022
Q3 		$51.8M Sell
4,356,920
-38,757
-0.9% -$560K 1.2% 27
2022
Q2 		$62.6M Buy
4,395,677
+523,523
+14% +$7.62M 1.62% 22
2022
Q1 		$80.6M Buy
3,872,154
+891,194
+30% +$15.7M 1.67% 24
2021
Q4 		$68.9M Buy
2,980,960
+2,171,097
+268% +$52.5M 1.01% 30
2021
Q3 		$24.1M Buy
809,863
+325,730
+67% +$10.4M 0.36% 57
2021
Q2 		$16.5M Hold
484,133
– – 0.25% 61
2021
Q1 		$15.9M Sell
484,133
-16,749
-3% -$660K 0.25% 62
2020
Q4 		$30.8M Buy
500,882
+882
+0.2% +$34.6K 0.52% 45
2020
Q3 		$17.8M Buy
+500,000
New +$18.4M 0.43% 52

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

RTW Investments's PMVP Position: Q4 2023 in Review

RTW Investments sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 2,375,785 shares — an estimated $14.6M sold.

RTW Investments first reported a position in PMVP in Q3 2020 and held it in 13 quarters. The position peaked at $80.6M in Q1 2022. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • RTW Investments reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • RTW Investments sold 2,375,785 PMV Pharmaceuticals shares in Q4 2023, an estimated $14.6M.
  • RTW Investments first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 13 quarters.
  • RTW Investments's PMV Pharmaceuticals position peaked at $80.6M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on RTW Investments's 13F filing for Q4 2023, filed 14 Feb 2024.